THCV, CBC, ands Rare Cannabinoids: Poised to Drive Cannabis Industry’s Next Wave of Growth
A new report from BayMedica shows THCV-infused products yielding 23.7% higher margins, CBC’s untapped potential, and gummies leading rare cannabinoid delivery—signaling major growth opportunities for cannabis brands and formulators.
